scholarly journals Multidisciplinary treatment of ischemic forms of diabetic foot

2019 ◽  
Vol 41 part 2 (2) ◽  
pp. 53-58
Author(s):  
Y. V. Ivanova ◽  
O. M. Klimova ◽  
I. A. Kryvoruchko ◽  
A. M. Korobov ◽  
V. O. Prasol ◽  
...  

Purpose of the study. The phototherapy, platelet growth factor and coating materials in the treatment complex using for improve the results of wound treatment in patients with the ischemic form of diabetic foot. Materials and methods. The analysis of the results of treatment of 48 patients with ischemic forms of diabetic foot syndrome has been performed in the work. The patients were divided into the study and comparative groups. The patients were treated at the clinic of the State institution «V. T. Zaitsev Institute of General and Emergency Surgery National Academy of Medical Sciences of Ukraine» from 2012–2018, and all patients had II stage diabetes mellitus and IV degree of ischemia by Fontaine. Patients in both groups performed open and hybrid reconstructions. In the patients of the study group, the developed treatment technology was applied, containing phototherapy and photodynamic therapy with a range of: λ 470, 525 or 405 nm in the preoperative period, closure with synthetic coating with application plasma enriched of transforming growth factor. The implementation of the developed tactics allowed to achieve complete wound healing in 91,7% of patients, partial healing – in 8,3% of patients. The terms treatment terms for these patients did not exceed 2 months, high amputation was not required. Conclusions. Plastic closure of the wounds of the lower extremities after revascularization operations in an ischemic diabetic foot syndrome is indicated in cases where wounds do not tend to spontaneous healing. The use of a treatment complex consisting of phototherapy and photodynamic therapy, the closure of wounds with a synthetic coating of transforming growth factor is the effective stimulator of development of granulation tissue in the wound, suitable for further autodermoplasty. Keywords: foot ischemic diabetic syndrome, dermoplasty, synthetic coatings, photodynamic therapy, platelet growth factor.

The aim of the study was to improve the results of wound treatment in patients with ischemic and neuro-ischemic forms of diabetic foot syndrome through the use of phototherapy, platelet growth factor and modern coating materials in the treatment complex. The paper presents the results of surgical treatment of 48 patients with ischemic and neuroischemic diabetic foot syndrome, which, in accordance with the objectives of the study, were divided into two groups — the study (24 patients) and comparative (24 patients). All patients suffered from diabetes mellitus type II and had IV degree of foot ischemia according to Fontaine. The following reconstructive operations were performed in both groups of patients: femoral-tibialis and femoral-popliteal shunting, as well as hybrid reconstructions. In patients of the study group, the treatment technology developed by us was applied. Using the developed tactics, it was possible to achieve complete healing of wounds in 91,7 % of patients and partial healing (over 50 %) in 8.3 % of patients in the study group. The terms of treatment of these patients did not exceed 2 months, the execution of high amputations was not required.


2002 ◽  
Vol 19 (6) ◽  
pp. 440-447 ◽  
Author(s):  
E. B. Jude ◽  
R. Blakytny ◽  
J. Bulmer ◽  
A. J. M. Boulton ◽  
M. W. J. Ferguson

2013 ◽  
Vol 31 (2) ◽  
pp. 65-71 ◽  
Author(s):  
Sérgio L. S. Souza ◽  
Patrícia F. Andrade ◽  
João S. Silva ◽  
Fabrine S. M. Tristão ◽  
Fernanda A. Rocha ◽  
...  

Nanoscale ◽  
2021 ◽  
Author(s):  
Jitang Chen ◽  
Si Li ◽  
Xin Liu ◽  
Sha Liu ◽  
Chen Xiao ◽  
...  

Photodynamic therapy (PDT) is frequently used for cancer treatment in the clinical settings. However, its applications in stroma-rich solid tumors, e.g., triple negative breast cancer, are limited by the abnormal...


Planta Medica ◽  
2019 ◽  
Vol 85 (08) ◽  
pp. 657-669 ◽  
Author(s):  
Zhang Pengzong ◽  
Li Yuanmin ◽  
Xiong Xiaoming ◽  
Deng Shang ◽  
Xiong Wei ◽  
...  

AbstractThe aim of the present study was to evaluate the wound healing potential and possible mechanism of action of the standardized extract of Boswellia serrata against the experimental model of diabetic foot ulcer. α-Boswellic acid was isolated from the standardized extract of B. serrata and characterized (HPLC, 1H-NMR, 13C-NMR, ESI-MS). Diabetes was induced in Sprague-Dawley rats by streptozotocin (55 mg/kg, i. p.), and wounds were created on the dorsal surface of the hind paw. B. serrata (100, 200, and 400 mg/kg, p. o.) was administered to the rats for 16 days. The HPLC analysis showed a single peak with a retention time of 12.51 min. The compound was identified with ESI-MS [M + Na]+ = 455.37 as α-boswellic acid. Treatment with B. serrata (200 and 400 mg/kg) significantly increased the rate of wound contraction via modulation of oxido-nitrosative stress and elevated the hydroxyproline level at the wound area. reverse transcription-PCR analysis revealed that streptozotocin-induced increases in TNF-α, interleukin-1β, interleukin-6, nuclear factor-kappa-light-chain-enhancer of activated B cells, and Bcl-2-associated X protein, and decreases in angiopoietin-1, Tie2, transforming growth factor beta 1, vascular endothelial growth factor, and collagen-1 mRNA expression were significantly inhibited by B. serrata. It also significantly reduced wound cellular necrosis as evaluated by flow cytometry using propidium iodide fluorescence intensity. Streptozotocin-induced histopathological alterations were also significantly ameliorated by B. serrata. In conclusion, standardized extracts of B. serrata exert its wound healing potential via orchestrating mechanisms, which include the inhibition of oxido-inflammatory markers (oxido-nitrosative stress, TNF-α, interleukins, and nuclear factor-kappa-light-chain-enhancer of activated B cells), increased collagen synthesis (hydroxyproline and collagen-1) and angiogenesis (Ang-1/Tie2), promoting growth factors (transforming growth factor beta 1 and vascular endothelial growth factor), and inhibition of apoptosis (Bcl-2-associated X protein) to accelerate wound healing in experimental delayed diabetic foot ulcer.


Sign in / Sign up

Export Citation Format

Share Document